Thurston Springer Miller Herd & Titak’s Orthofix Medical OFIX Stock Holding History
Bought
Maintained
Sold
Other funds holding OFIX
Thurston Springer Miller Herd & Titak's OFIX Position: Q3 2026 in Review
Thurston Springer Miller Herd & Titak sold out of Orthofix Medical (OFIX) in Q3 2026, closing a stake of 600 shares — an estimated $5.48K sold.
Thurston Springer Miller Herd & Titak first reported a position in OFIX in Q2 2025 and held it in 3 quarters. The position peaked at $5.48K in Q2 2026. 98 funds tracked by Wall St. Rank hold OFIX as of Q3 2026.
- Thurston Springer Miller Herd & Titak reported no remaining Orthofix Medical position as of Q3 2026 after selling out during the quarter.
- Thurston Springer Miller Herd & Titak sold 600 Orthofix Medical shares in Q3 2026, an estimated $5.48K.
- Thurston Springer Miller Herd & Titak first reported a position in Orthofix Medical in Q2 2025 and held it in 3 quarters.
- Thurston Springer Miller Herd & Titak's Orthofix Medical position peaked at $5.48K in Q2 2026.
- 98 funds tracked by Wall St. Rank held Orthofix Medical as of Q3 2026.
Based on Thurston Springer Miller Herd & Titak's 13F filing for Q3 2026, filed 14 Oct 2026.